ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Obesity
Foot Ulcer
Overweight

Diabetes trials near Budapest, Budapest, HUN:

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Budapest, Hungary and 59 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Budapest, Hungary and 648 other locations

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Enrolling
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Drug: Maridebart cafraglutide
Drug: Placebo

Phase 3

Amgen
Amgen

Budapest, Hungary and 159 other locations

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: AZD5004
Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca
AstraZeneca

Budapest, Hungary and 96 other locations

index of 27 kg/m² or more. People can take part if they have type 2 diabetes and if they are currently being treated only with diet and exer...

Active, not recruiting
Diabetes Mellitus, Type 2
Obesity
Drug: Survodutide
Drug: Placebo

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Kistarcsa, Hungary and 145 other locations

This study will look at how much CagriSema helps participants with type 2 diabetes lower their blood sugar and body weight. CagriSema is a n...

Active, not recruiting
Type 2 Diabetes
Drug: Semaglutide
Drug: Placebo

Phase 3

Novo Nordisk
Novo Nordisk

Budapest, Hungary and 48 other locations

help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which cannot be prescribed by doct...

Enrolling
Type 2 Diabetes (T2D)
Drug: Placebo (NNC0487-0111 oral)
Drug: NNC0487-0111 oral

Phase 2

Novo Nordisk
Novo Nordisk

Budapest, Hungary and 105 other locations

at Week 52 in participants with overweight or obesity without diabetes mellitus (Cohort A) and in participants with overweight or obesity wi...

Active, not recruiting
Type 2 Diabetes Mellitus
Overweight
Drug: Placebo
Biological: Maridebart Cafraglutide

Phase 2

Amgen
Amgen

Budapest, Hungary and 78 other locations

This study will look at how much CagriSema lowers blood sugar and body weight in people with type 2 diabetes. CagriSema is a new investigati...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Cagrilintide
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Budapest, Hungary and 143 other locations

This study will look if CagriSema can lower kidney damage in people with chronic kidney disease (CKD), type 2 diabetes (T2D) and overweight ...

Active, not recruiting
Type 2 Diabetes
Chronic Kidney Disease
Drug: Cagrilintide
Drug: Semaglutide

Phase 2

Novo Nordisk
Novo Nordisk

Budapest, Hungary and 122 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems